Editorial: anti-TNF combination therapy for inflammatory bowel disease-one size does not fit all

Aliment Pharmacol Ther. 2022 Mar;55(6):750-751. doi: 10.1111/apt.16803.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Infliximab / therapeutic use
  • Tumor Necrosis Factor Inhibitors* / therapeutic use

Substances

  • Tumor Necrosis Factor Inhibitors
  • Infliximab